Lv62
2888 积分 2024-12-01 加入
BMS-986278, a lysophosphatidic acid 1 (LPA1) receptor antagonist, in healthy participants: A single/multiple ascending dose (SAD/MAD) phase 1 study Giridhar Tirucherai Dale Yu Ratna Revankar Show More
5天前
已关闭
A Decade of FDA-Approved Drugs (2010-2019): Trends and Future Directions
18天前
已完结
Understanding factors influencing the implementation of medicine risk communications by healthcare professionals in clinical practice: a systematic review using the Theoretical Domains Framework
1个月前
已关闭
Sunvozertinib: First Approval
1个月前
已完结
Hallmarks of the ageing lung - 10 years later
1个月前
已关闭
Role of growth factors and the wound healing response in age-related macular degeneration
2个月前
已完结
TGFbeta pathobiology in the eye
2个月前
已完结
Comparison among adjuvant treatments for primary pterygium: a network meta-analysis
2个月前
已完结
Efficacy of bevacizumab in the treatment of pterygium: An updated meta-analysis of randomized controlled trials
2个月前
已完结
Adjuvant Use of Topical 0.05% Cyclosporine A in Primary Pterygium Recurrence Rate: A Systematic Review and Meta-analysis
3个月前
已完结
皖公网安备34019202002308
